TOPOFEN™
Chronic Inflammatory Joint Pain / Temporomandibular Joint (TMJ) Pain
Pre-clinicalActive
Key Facts
Indication
Chronic Inflammatory Joint Pain / Temporomandibular Joint (TMJ) Pain
Phase
Pre-clinical
Status
Active
Company
About Achelios Therapeutics
Achelios Therapeutics is a private, pre-revenue biotech founded in 2016 and based in Durham, North Carolina. The company is developing 'New Therapeutic Entities' (NTEs)—topical formulations designed to deliver large quantities of NSAIDs through the skin directly to the site of pain and inflammation. Its lead program, TOPOFEN™, appears to be in clinical development for conditions like TMJ pain and arthralgia, aiming to provide localized relief with potentially reduced systemic side effects compared to oral NSAIDs.
View full company profile